2020
DOI: 10.5599/admet.850
|View full text |Cite
|
Sign up to set email alerts
|

Global testing of a consensus solubility assessment to enhance robustness of the WHO biopharmaceutical classification system

Abstract: The WHO Biopharmaceutical Classification System (BCS) is a practical tool to identify active pharmaceutical ingredients (APIs) that scientifically qualify for a waiver of in vivo bioequivalence studies. The focus of this study was to engage a global network of laboratories to experimentally quantify the pH-dependent solubility of the highest therapeutic dose of 16 APIs using a harmonized protocol. Intra-laboratory variability was ≤5 %, and no apparent association of inter-laboratory variability with API solubi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
7
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 7 publications
(7 citation statements)
references
References 29 publications
0
7
0
Order By: Relevance
“…Because the bioequivalence cannot be established if there is a difference (8-10). (37). Generic versions of drugs must show bioequivalence (BE) to the corresponding brandname versions before they may be sold (38).…”
Section: Figure 3: Bcs Class Drug Biowaviersmentioning
confidence: 99%
See 1 more Smart Citation
“…Because the bioequivalence cannot be established if there is a difference (8-10). (37). Generic versions of drugs must show bioequivalence (BE) to the corresponding brandname versions before they may be sold (38).…”
Section: Figure 3: Bcs Class Drug Biowaviersmentioning
confidence: 99%
“…Replacement therapies and other essential pharmaceuticals, as well as backup measures in case of shortages. [37,38], are examples of medication treatment services that should be readily available without interruption, in our opinion.…”
Section: Higher Drug Consumption During Pandemicmentioning
confidence: 99%
“…However, using them to measure a new chemical’s solubility with useful accuracy is still a practical problem . The gold standard of saturation shake-flask measurement is low throughput, and it would take state-of-the-art techniques to achieve a low interlaboratory variability . Factors like crystallinity, polymorphism, compound purity, particle size, and so forth all impact interlaboratory reproducibility.…”
Section: Introductionmentioning
confidence: 99%
“…The single particle analysis was useful to study local recrystallization occurring on the particle surface, providing crucial information to understand surface chemistry effects during storage and dissolution. Dissolution was also studied by Gigante et al [14] who set out to perform a global evaluation of the WHO harmonised protocol for equilibrium solubility experiments. The study focused on measurement of 16 compounds for which the biopharmaceutics classification had previously been performed.…”
mentioning
confidence: 99%
“…Dissolution was also studied by Gigante et al . [ 14 ] who set out to perform a global evaluation of the WHO harmonised protocol for equilibrium solubility experiments. The study focused on measurement of 16 compounds for which the biopharmaceutics classification had previously been performed.…”
mentioning
confidence: 99%